Hennion & Walsh Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $237K | Sell |
|
|||||
|
2025
Q2 | $308K | Sell |
|
|||||
|
2025
Q1 | $344K | Sell |
|
|||||
|
2024
Q4 | $402K | Buy |
|
|||||
|
2024
Q3 | $296K | Buy |
|
|||||
|
2024
Q2 | $434K | Buy |
|
|||||
|
2024
Q1 | $226K | Sell |
|
|||||
|
2023
Q4 | $207K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $333K | Sell |
|
|||||
|
2022
Q2 | $316K | Sell |
|
|||||
|
2022
Q1 | $573K | Buy |
|
|||||
|
2021
Q4 | $584K | Sell |
|
|||||
|
2021
Q3 | $600K | Sell |
|
|||||
|
2021
Q2 | $476K | Buy |
|
|||||
|
2021
Q1 | $342K | Buy |
|